Began global shipments of Xenium Analyzer, the highest throughput instrument for subcellular In Situ profiling PLEASANTON, Calif., Dec. 8, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a ...

Ductal carcinoma in situ (DCIS), cancer cell growth that starts in the milk ducts, is the most common form of breast cancer. However, why some DCIS progress to invasive carcinoma but others remain ...

Xenium In Situ demonstrates higher transcript counts per gene in new comparison study of three spatial imaging platforms PLEASANTON, Calif., Dec. 13, 2023 /PRNewswire/ -- 10x Genomics, Inc ...

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that it has started shipping its new Xenium Prime 5K Pan-Tissue and Pathways panel. The new panel ...

PLEASANTON, Calif., March 21, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of its Xenium multi ...

I. 10X Genomics Xenium (off-the-shelf panel; 1-100 add-on genes) BASIC SERVICE Fees with an off-the-shelf panel Off-the-shelf currently includes choice of 9 predesigned panels of 247-380 genes in ...

PLEASANTON, Calif., Dec. 13, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that a new non-peer-reviewed study has ...